Proliferative Responses of Peripheral Blood Lymphocytes of Mice and Humans Stimulated with Recombinant Interleukin 2

• Published in: Pathobiology (Basel) Vol. 61; no. 1; pp. 43 - 50
• Main Authors: Zaleski, Marek B., Cunningham, Roger K.
• Format: Journal Article
• Language: English
• Published: Basel, Switzerland 01.01.1993
• Subjects: Animals; Calcimycin - pharmacology; Cells, Cultured; Drug Interactions; Female; Humans; Interleukin-2 - pharmacology; Ionomycin - pharmacology; Lymphocyte Activation - drug effects; Lymphocytes - drug effects; Lymphocytes - immunology; Male; Mice; Mice, Inbred AKR; Mice, Inbred C3H; Recombinant Proteins - pharmacology; rIL-2 Activated Lymphocytes; Species Specificity; Tetradecanoylphorbol Acetate - pharmacology; Phorbol; Peripheral blood lymphocytes; Interleukin 2; Ionophores
• ISSN: 1015-2008; 1423-0291
• DOI: 10.1159/000163759

In vitro proliferative responses of human and murine peripheral blood lymphocytes (PBL) were studied. The cells were stimulated with recombinant interleukin 2 (IL-2) or with a mixture of phorbol-13-myristate-12-acetate with either IL-2 or calcium ionophores. Proliferation of human PBL could be induced by doses of human IL-2 or phorbol that were much lower than those required to produce responses of murine cells. However, the magnitude of the responses of human PBL was definitely lower than that of the responses of murine PBL. Murine IL-2 did not induce proliferation of human PBL, but it synergized with phorbol. The responses of murine PBL reflected the previously described strain differences in responses of spleen cells that were shown to be under complex polygenic control. The proliferation of murine spleen cells could be induced with human, as well as murine IL-2, and both species of IL-2 synergized with phorbol. While no clear-cut low and high responders could be identified among normal healthy human subjects, 2 individuals produced consistently low responses to IL-2 and 1 individual displayed low responses to phorbol and calcium ionophore A23187. Available data suggest, but do not allow a firm conclusion, that proliferative responses of human PBL are under genetic control, perhaps as complex as that reported for mice.